Watson unveils generic version of Prometrium capsules
As per the agreement, Abbott manufactures all dosage strengths of the authorized generic product and supplies to Watson. Watson markets and distributes the product in the US and
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.